Stock screener

BBIO

Conviction 65HealthcareScan · Mon, Jul 20, 2026
BBIO$80.77-0.75%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
Gilbert Cisneros
3
2
2
5
4
Vol MA14 4.6M
Apr 20May 6May 26Jun 11Jul 1Jul 20
BridgeBio Pharma, Inc.PHARMACEUTICAL PREPARATIONSwww.bridgebio.com ↗
Price80.77
Change-0.75%
Gap+0.57%
Rel volume1.37×
Avg volume5.33M
Avg $ vol416.51M
SMA 2077.37
SMA 5071.20
SMA 20070.10
Price vs 50+13.45%
Price vs 200+15.23%
MA stackbullish
50/200 cross—
Supertrendup · 77.34
RSI (14)59
MACD hist0.02
MACD cross—
Stoch %K / %D42 / 45
ADX (14)36
+DI / −DI31 / 15
RSI divergence—
MACD divergence—
ATR %+4.25%
ADR %3.96%
52w high90.17
52w low44.81
From 52w high-10.42%
Above 52w low+80.25%
New 52w highNo
SqueezeOff
Bollinger width31.59%
%B0.64
Donchian pos53.37%
Donchian high93.42
Donchian low66.30
AVWAP (52w high)85.87
vs AVWAP high-5.94%
AVWAP (52w low)67.87
vs AVWAP low+19.01%
OBV trendUp
Chaikin MF (20)-0.06
Today vs 20d1.37×
Avg vol (14d)4.6M
Avg vol (20d)5.33M
Avg $ vol (20d)416.51M
Market cap15.82B
RS 3m (vs SPY)-0.94%
RS 6m (vs SPY)-3.20%
RS line new highNo
Trend template6/8
Technical rank77.8
1 week-2.78%
1 month+19.85%
3 months+5.24%
6 months+5.91%
1 year+72.81%
YTD+3.24%
P/E—
P/B-6.94
P/S31.51
P/FCF-35.39
EPS-3.78
Div yield0.01%
ROE—
ROA—
Debt/Eq-0.00
Current1.52
EV/EBITDA-28.85
Gross margin—
Net margin—
Rev growth126.26%
EPS growth—
Price target107.39
Target upside32.96%
Analyst ratingBuy
Institutional109.22%
Ent. value14.94B
Revenue194.51M
Net income-69K
Gross profit—
Free cash flow-447.01M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out195.86M
Employees839
ListedThu, Jun 27, 2019
Free float149.14M
Float %76.2%
Short interest24.1M
Days to cover4.5d
Short volume55.1%
Squeeze score71 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.84 vs −$0.70
Last surprise-20.0% miss
Setup gradeB
Conviction65 / 100
Pattern quality—
Tech rank77.8 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance86.33
Support64.05
Days since event—
Candle confirm—
News sentiment—

Financials as of Sun, Jun 30, 2019 · quarterly.

Congress activity

Disclosed STOCK Act trades in BBIO · 4 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2026-05-11
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2026-03-19
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-09-22
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-08-08
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in BBIO · 3 buys · 7 sells

InsiderSideShares
Cook Jennifer E.
Director · Stock Option (Right to Buy) · 2026-07-09
Exercise17.17K
Ellis Andrea
Director · Common Stock · 2026-07-09
Exercise17.17K
Ellis Andrea
Director · Common Stock · 2026-07-09
Sell17.17K
Ellis Andrea
Director · Stock Option (right to buy) · 2026-07-09
Exercise17.17K
Cook Jennifer E.
Director · Common Stock · 2026-07-09
Exercise112.42K
Cook Jennifer E.
Director · Common Stock · 2026-07-09
Exercise17.17K
Cook Jennifer E.
Director · Common Stock · 2026-07-09
Sell36.17K
Cook Jennifer E.
Director · Common Stock · 2026-07-09
Sell112.42K
Cook Jennifer E.
Director · Stock Option (Right to Buy) · 2026-07-09
Exercise19K
Cook Jennifer E.
Director · Stock Option (Right to Buy) · 2026-07-09
Exercise112.42K

SEC filings

EDGAR filings in BBIO · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.